Literature DB >> 7695271

Effects of antifungal agent combinations administered simultaneously and sequentially against Aspergillus fumigatus.

S Maesaki1, S Kohno, M Kaku, H Koga, K Hara.   

Abstract

The in vitro effects of antifungal agent combinations administered simultaneously and sequentially against 15 strains of Aspergillus fumigatus were tested by the yeast-malt broth method. The synergistic effect of the combination of amphotericin B (AMPH) and miconazole was observed in nine strains (60%). However, the combinations of AMPH and fluconazole, AMPH and ketoconazole, and AMPH and itraconazole administered simultaneously showed antagonistic effects against three (20%), five (34%), and four (26%) strains, respectively. The effects of combinations of azole antifungal agents administered simultaneously were indifferent or antagonistic against A. fumigatus. In experiments measuring the effects of sequentially administered antifungal agents, however, pretreatment with AMPH and then azole antifungal agents exhibited better in vitro efficacy than that found in experiments measuring the effects of simultaneously administered AMPH and azole compounds.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7695271      PMCID: PMC188294          DOI: 10.1128/AAC.38.12.2843

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.

Authors:  D W Denning; L H Hanson; A M Perlman; D A Stevens
Journal:  Diagn Microbiol Infect Dis       Date:  1992-01       Impact factor: 2.803

2.  A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis.

Authors:  J E Bennett; W E Dismukes; R J Duma; G Medoff; M A Sande; H Gallis; J Leonard; B T Fields; M Bradshaw; H Haywood; Z A McGee; T R Cate; C G Cobbs; J F Warner; D W Alling
Journal:  N Engl J Med       Date:  1979-07-19       Impact factor: 91.245

3.  Rapid and highly reproducible method for antifungal susceptibility testing of Aspergillus species.

Authors:  H Yamada; S Kohno; S Maesaki; H Koga; M Kaku; K Hara; H Tanaka
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

4.  A method for testing for synergy with any number of agents.

Authors:  M C Berenbaum
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

5.  Therapy of murine aspergillosis with amphotericin B in combination with rifampin of 5-fluorocytosine.

Authors:  J Arroyo; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

6.  In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.

Authors:  C E Hughes; C Harris; J A Moody; L R Peterson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

7.  Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

8.  Collaborative investigation of variables in susceptibility testing of yeasts.

Authors:  M A Pfaller; M G Rinaldi; J N Galgiani; M S Bartlett; B A Body; A Espinel-Ingroff; R A Fromtling; G S Hall; C E Hughes; F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

9.  Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics.

Authors:  J Brajtburg; D Kobayashi; G Medoff; G S Kobayashi
Journal:  J Infect Dis       Date:  1982-08       Impact factor: 5.226

10.  The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis.

Authors:  A Schaffner; P G Frick
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

View more
  10 in total

Review 1.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

Review 2.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: an E-test-based strategy.

Authors:  D P Kontoyiannis; R E Lewis; N Sagar; G May; R A Prince; K V Rolston
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

4.  Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolates.

Authors:  D T A Te Dorsthorst; P E Verweij; J F G M Meis; N C Punt; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 5.  Antifungal combination therapy: clinical potential.

Authors:  John W Baddley; Peter G Pappas
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Current and emerging azole antifungal agents.

Authors:  D J Sheehan; C A Hitchcock; C M Sibley
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

7.  In vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models.

Authors:  D T A Te Dorsthorst; P E Verweij; J F G M Meis; N C Punt; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

8.  In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans.

Authors:  M H Nguyen; F Barchiesi; D A McGough; V L Yu; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

9.  New diphenylphosphane derivatives of ketoconazole are promising antifungal agents.

Authors:  Rodrigo F M de Almeida; Filipa C Santos; Krzysztof Marycz; Michalina Alicka; Anna Krasowska; Jakub Suchodolski; Jarosław J Panek; Aneta Jezierska; Radosław Starosta
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

10.  Initial Results of the International Efforts in Screening New Agents against Candida auris.

Authors:  Vanice Rodrigues Poester; Lívia Silveira Munhoz; Jéssica Louise Benelli; Aryse Martins Melo; Abdullah M S Al-Hatmi; David J Larwood; Marife Martinez; David A Stevens; Melissa Orzechowski Xavier
Journal:  J Fungi (Basel)       Date:  2022-07-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.